X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1888) 1888
Book Review (376) 376
Publication (154) 154
Book / eBook (34) 34
Book Chapter (13) 13
Magazine Article (8) 8
Conference Proceeding (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1661) 1661
humans (1072) 1072
ophthalmology (1054) 1054
animals (963) 963
male (723) 723
female (624) 624
cornea (461) 461
angiogenesis (406) 406
corneal neovascularization - drug therapy (405) 405
neovascularization (376) 376
disease models, animal (365) 365
corneal neovascularization (348) 348
eye diseases (341) 341
mice (327) 327
adult (311) 311
middle aged (299) 299
rabbits (293) 293
bevacizumab (274) 274
sense organs (267) 267
endothelial growth-factor (261) 261
corneal neovascularization - pathology (241) 241
aged (236) 236
rats (210) 210
treatment outcome (208) 208
expression (206) 206
transplantation (193) 193
cornea - pathology (189) 189
vascular endothelial growth factor (188) 188
genetic structures (183) 183
administration, topical (179) 179
inflammation (178) 178
angiogenesis inhibitors - therapeutic use (175) 175
angiogenesis inhibitors - administration & dosage (173) 173
vascular endothelial growth factor a - antagonists & inhibitors (170) 170
cornea - drug effects (169) 169
corneal transplantation (161) 161
analysis (156) 156
cells (155) 155
surgery (152) 152
corneal neovascularization - metabolism (149) 149
inhibition (148) 148
macular degeneration (146) 146
care and treatment (145) 145
eye (142) 142
health aspects (138) 138
keratitis (132) 132
pharmacology & pharmacy (130) 130
abridged index medicus (128) 128
research (128) 128
visual acuity (125) 125
cells, cultured (122) 122
in-vitro (120) 120
therapy (119) 119
vegf (119) 119
wound healing (119) 119
follow-up studies (118) 118
mice, inbred c57bl (118) 118
mice, inbred balb c (114) 114
cornea - blood supply (113) 113
ophthalmic solutions (112) 112
medicine (110) 110
penetrating keratoplasty (110) 110
vascular endothelial growth factor a - metabolism (106) 106
stem cells (105) 105
research article (104) 104
adolescent (102) 102
retrospective studies (101) 101
aged, 80 and over (100) 100
antibodies, monoclonal, humanized (100) 100
medicine, research & experimental (100) 100
wound healing - drug effects (98) 98
article (97) 97
in-vivo (97) 97
angiogenesis inhibitors - pharmacology (93) 93
cornea - metabolism (92) 92
cell biology (91) 91
prospective studies (90) 90
corneal diseases (89) 89
cancer (87) 87
avastin (86) 86
immunohistochemistry (86) 86
medicine & public health (86) 86
corneal neovascularization - chemically induced (85) 85
rats, sprague-dawley (85) 85
corneal neovascularization - prevention & control (84) 84
model (84) 84
apoptosis (82) 82
biochemistry & molecular biology (82) 82
time factors (82) 82
rodents (80) 80
neovascularization, pathologic - drug therapy (78) 78
corneal neovascularization - etiology (77) 77
multidisciplinary sciences (77) 77
corneal diseases - pathology (75) 75
dose-response relationship, drug (75) 75
glaucoma (75) 75
lymphangiogenesis (75) 75
risk factors (74) 74
young adult (74) 74
child (73) 73
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1865) 1865
German (16) 16
French (12) 12
Russian (12) 12
Chinese (11) 11
Spanish (8) 8
Japanese (5) 5
Portuguese (5) 5
Bulgarian (1) 1
Croatian (1) 1
Hebrew (1) 1
Korean (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Graefe's Archive for Clinical and Experimental Ophthalmology, ISSN 0721-832X, 2009, Volume 247, Issue 10, pp. 1375 - 1382
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 12/2018, Volume 552, Issue 1-2, pp. 164 - 170
The antibody avastin® (Ava) has been clinically to treat various intraocular neovascular diseases, but suffering from the rapid clearance and short shelf-life... 
Sustained release | Anti-VEGF | Corneal neovascularization | Thermosensitive hydrogel | Avastin | KERATOPLASTY | PHOTODYNAMIC THERAPY | ANGIOGENESIS | OCULAR DRUG-DELIVERY | RELEASE | Avastin (R) | INHIBITION | PHARMACOKINETICS | TOPICAL BEVACIZUMAB | PHARMACOLOGY & PHARMACY | SHORT-TERM | ENDOTHELIAL GROWTH-FACTOR | Corneal Neovascularization - drug therapy | Delayed-Action Preparations - chemistry | Hydrogels - pharmacokinetics | Polyethylene Glycols - chemistry | Delayed-Action Preparations - administration & dosage | Angiogenesis Inhibitors - administration & dosage | Hydrogels - administration & dosage | Polyesters - administration & dosage | Delayed-Action Preparations - pharmacokinetics | Disease Models, Animal | Bevacizumab - chemistry | Eye - metabolism | Drug Administration Routes | Rabbits | Bevacizumab - administration & dosage | Bevacizumab - pharmacokinetics | Polyethylene Glycols - pharmacokinetics | Angiogenesis Inhibitors - pharmacokinetics | Polyethylene Glycols - administration & dosage | Polyesters - chemistry | Polyesters - pharmacokinetics | Injections | Animals | Corneal Neovascularization - metabolism | Drug Liberation | Hydrogels - chemistry | Angiogenesis Inhibitors - chemistry | Drugs | Ethylene glycol | Drug delivery systems | Biological products | Endothelial growth factors | Analysis | Ophthalmology | Neovascularization | Biomedical engineering | Vehicles | Index Medicus
Journal Article
Journal Article
Journal Article
Ophthalmology, ISSN 0161-6420, 2014, Volume 121, Issue 9, pp. 1683 - 1692
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 05/2011, Volume 208, Issue 5, pp. 973 - 986
Angiogenesis plays an essential role in several diseases of the eye and in the growth of solid tumors, but existing antiangiogenic therapies have limited... 
RETINAL NEOVASCULARIZATION | MEDICINE, RESEARCH & EXPERIMENTAL | NK CELLS | OXYGEN-INDUCED RETINOPATHY | TOPICAL BEVACIZUMAB | MACULAR DEGENERATION | TUMOR ANGIOGENESIS | MALIGNANT-MELANOMA | IMMUNOLOGY | EXPERIMENTAL CORNEAL NEOVASCULARIZATION | SUBCONJUNCTIVAL BEVACIZUMAB | INTRAVITAL MICROSCOPY | Retinal Diseases - genetics | Colonic Neoplasms - genetics | Melanoma - blood supply | Colonic Neoplasms - drug therapy | Corneal Neovascularization - drug therapy | Humans | Male | Retinal Diseases - metabolism | Corneal Neovascularization - genetics | Antigens, CD - genetics | Colonic Neoplasms - metabolism | Antigens, CD - metabolism | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Neovascularization, Pathologic - pathology | Melanoma - genetics | Fibroblast Growth Factor 2 - metabolism | Retinal Diseases - pathology | Female | Melanoma - metabolism | Rabbits | Colonic Neoplasms - blood supply | Melanoma - pathology | GPI-Linked Proteins - metabolism | Animals | Corneal Neovascularization - metabolism | Fibroblast Growth Factor 2 - genetics | Mice, Nude | Neovascularization, Pathologic - drug therapy | Colonic Neoplasms - pathology | Cyclophosphamide - pharmacology | Melanoma - drug therapy | Neovascularization, Pathologic - genetics | Mice | Mice, Inbred BALB C | Neovascularization, Pathologic - metabolism | Retinal Diseases - drug therapy | Antibodies, Monoclonal, Murine-Derived - pharmacology | Receptors, Immunologic - genetics | Corneal Neovascularization - pathology | Receptors, Immunologic - metabolism | GPI-Linked Proteins - genetics | Index Medicus | Retinal Diseases | Antibodies, Monoclonal, Murine-Derived | Melanoma | Neovascularization, Pathologic | GPI-Linked Proteins | Antineoplastic Combined Chemotherapy Protocols | Life Sciences | Corneal Neovascularization | Cyclophosphamide | Fibroblast Growth Factor 2 | Receptors, Immunologic | Colonic Neoplasms | Antigens, CD | Cancer
Journal Article
Experimental Eye Research, ISSN 0014-4835, 08/2014, Volume 125, pp. 118 - 127
Journal Article